A man rides past an Aurobindo Pharma production facility in Jadcherla, India. (Photographer: Prashanth Vishwanathan/Bloomberg)
Shares of Aurobindo Pharma Ltd. rose to the highest in a month after the Hyderabad-based drugmaker reported its best quarterly revenue and operating profit in at least two years.
The company's revenue rose 15.8% year-on-year to Rs 6,483.4 crore in the quarter ended September, the highest in at least eight quarters, according to an exchange filing. That compares with the Rs 6,218-crore consensus estimate of analysts tracked by Bloomberg.
Its net profit rose 26% over the year earlier to Rs 806.2 crore, against Rs 778 crore forecast.
